Inventor · disambiguated record
Camilo Rojas
Also filed as: ROJAS CAMILO
7 granted patents·3 pending applications·0 citations·filing 2012–2023
68Inventor score
Top patents by PatentIndex Score
10 records- 0170US2024115574A1INHIBITION OF nSMase FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTIONUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 0262US11759466B2Inhibition of nSMase for the treatment of human immunodeficiency virus infectionUNIV JOHNS HOPKINS·Filed 2019·Granted Sep 19, 2023·0 cites·14 claims
- 0357US11766423B22,6-dimethoxy-4-(5-phenyl-4-thiophene-2-yl-1H-imidazol-2-yl)-phenol (DPTIP) a small molecule inhibitor of neutral sphingomyelinase 2 (nSMase-2) for the treatment of neurodegenerative and oncologic diseasesUNIV JOHNS HOPKINS·Filed 2019·Granted Sep 26, 2023·0 cites·2 claims
- 0455US2024002395A1Compounds and their use for treating neuropathic painUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 0546US12195450B2Small molecule neutral sphingomyelinase 2 (nSMase2) inhibitorsUNIV JOHNS HOPKINS·Filed 2020·Granted Jan 14, 2025·0 cites·12 claims
- 0645US8778688B2High-throughput methods for determining pharmacological levels of plasma D-serineUNIV JOHNS HOPKINS·Filed 2012·Granted Jul 15, 2014·0 cites·10 claims
- 0741US9505753B2Inhibitors of D-amino acid oxidaseUNIV JOHNS HOPKINS·Filed 2013·Granted Nov 29, 2016·0 cites·5 claims
- 0840US8771975B2Quantitation of GCP activity in biological samplesSLUSHER BARBARA S·Filed 2012·Granted Jul 8, 2014·0 cites·20 claims
- 0933US11427590B2Small molecule inhibitors of neutral sphingomyelinase 2 (nSMase2) for the treatment of neurodegenerative diseasesUNIV JOHNS HOPKINS·Filed 2018·Granted Aug 30, 2022·0 cites·17 claims
- 1029US2018267067A1Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonistsUNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Camilo Rojas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →